BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32659223)

  • 21. Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
    Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
    BMC Med; 2023 Aug; 21(1):294. PubMed ID: 37553571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.
    Tshering G; Dorji PW; Chaijaroenkul W; Na-Bangchang K
    Am J Trop Med Hyg; 2018 Jun; 98(6):1788-1797. PubMed ID: 29637880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between circulating MicroRNA-150 level and cholangiocarcinoma.
    Salem PES; Ghazala RA; El Gendi AM; Emara DM; Ahmed NM
    J Clin Lab Anal; 2020 Nov; 34(11):e23397. PubMed ID: 33161598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.
    Singh S; Tang SJ; Sreenarasimhaiah J; Lara LF; Siddiqui A
    Dig Dis Sci; 2011 Aug; 56(8):2491-6. PubMed ID: 21516323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
    Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A
    Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
    Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D
    Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
    Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
    J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
    J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.
    Loosen SH; Roderburg C; Kauertz KL; Koch A; Vucur M; Schneider AT; Binnebösel M; Ulmer TF; Lurje G; Schoening W; Tacke F; Trautwein C; Longerich T; Dejong CH; Neumann UP; Luedde T
    Sci Rep; 2017 Dec; 7(1):16975. PubMed ID: 29208940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
    Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
    Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
    Trilianos P; Selaru F; Li Z; Gurakar A
    Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.
    Wang B; Chen L; Chang HT
    Biomark Med; 2016 Jun; 10(6):613-9. PubMed ID: 27232281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
    Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.